Alnylam Pharmaceuticals
ALNY
#441
Rank
S$68.91 B
Marketcap
S$521.66
Share price
1.97%
Change (1 day)
60.91%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company